Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Bicalutamide vs Watchful Waiting in Asymptomatic Prostate Cancer
NCT00014586Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2001
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bicalutamide in prostate cancer (PCa), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2001; status: terminated.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00014586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014586.